Will Resistance be a Problem for New CLL Drugs?

patientpower has 2343 videos Subscribe Here

Description: There's now some early evidence that not everyone responds well or long-term to one of the promising new drugs for CLL, Ibrutinib. The problem is a patient's cancer cells become resistant to the medicine. This has happened before and in other leukemias. Dr. Jeff Sharman from US Oncology reports on the news from a meeting of world CLL experts and puts this new story of resistance in perspective.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 09/23/13
Added : 4 years ago
Category : Other